Successful Treatment of Hemophagocytic Lymphohistiocytosis Associated with Lupus Nephritis by Using Mycophenolate Mofetil
An estimated 0.9% to 2.4% of patients with systemic lupus erythematosus (SLE) also have hemophagocytic lymphohistiocytosis (HLH). HLH associated with autoimmune diseases is often refractory to corticosteroid treatment; thus, additional immunosuppressive drugs, such as cyclosporine, cyclophosphamide,...
Main Authors: | Takashi Nawata, Makoto Kubo, Kosaku Shiragami, Yukinori Nakamura, Masafumi Yano |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2017-01-01
|
Series: | Case Reports in Rheumatology |
Online Access: | http://dx.doi.org/10.1155/2017/4159727 |
Similar Items
-
Mycophenolate mofetil in the treatment of lupus nephritis
by: Patrick FK Yong, et al.
Published: (2008-06-01) -
The Effectiveness and Safety of Mycophenolate Mofetil in Lupus Nephritis
by: Elyan, Mazen
Published: (2008) -
Successful Treatment with Mycophenolate Mofetil and Tacrolimus in Juvenile Severe Lupus Nephritis
by: Tomoo Kise, et al.
Published: (2015-01-01) -
Off-lable uses of mycophenolate mofetil: lupus nephritis
by: B. Fernández-García, et al.
Published: (2015-07-01) -
Use of mycophenolate mofetil (MMF) in lupus nephritis (LN) in children
by: Indaco R, et al.
Published: (2008-09-01)